Scipher Medicine
PrivateLast Round
PIPE
Jul 8, 2026
Est. Valuation
$180M
Total Funding Raised
$232.85M
Company Overview
Scipher Medicine is a biotechnology company that provides a precision medicine platform to identify the most effective drug for patients with autoimmune diseases based on their unique biological profiles and molecular signature tests.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scipher Medicine Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Scipher Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Jul 8, 2026 | ||||
| Series D Extension | Jul 30, 2024 | ||||
| Series D | Feb 24, 2022 | ||||
| Series C | Mar 24, 2021 | ||||
| Series B | Feb 19, 2020 | ||||
Series A | Sep 6, 2018 |
Key People
Founding team and executive leadership
Scipher Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granpool Innovative Investments | Series B, Seed |
| HV Fund | Series D |
| Kaiser Permanente Ventures | Series B |
| Khosla Ventures | Series B, Series C, PIPE, Series D, Series A |
| TD Securities | Series D |
| Blue Owl Capital | Series D |
| Neuberger Berman | PIPE, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2025
Partnered with InnoSIGN Inc. to analyze immune-mediated diseases.
Scipher Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scipher Medicine's valuation, stock price, and market status.